{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T14:41:55Z","timestamp":1793976115365,"version":"4.8.0"},"reference-count":155,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.phymed.2021.153694","type":"journal-article","created":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T18:58:47Z","timestamp":1628103527000},"page":"153694","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":96,"special_numbering":"C","title":["Hydroxysafflor yellow A, a natural compound from Carthamus tinctorius L with good effect of alleviating atherosclerosis"],"prefix":"10.1016","volume":"91","author":[{"given":"Xinyan","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengting","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2021.153694_bib0001","doi-asserted-by":"crossref","unstructured":"Ali, D.C., Naveed, M., Gordon, A., Majeed, F., Saeed, M., Ogbuke, M.I., Atif, M., Zubair, H.M., Li, C.X., 2020. \u03b2-Adrenergic receptor, an essential target in cardiovascular diseases. Heart Fail Rev. 25(2), 343-354.","DOI":"10.1007\/s10741-019-09825-x"},{"issue":"9","key":"10.1016\/j.phymed.2021.153694_bib0002","first-page":"119","article-title":"Antioxidant and Pro-Oxidant Properties of Carthamus Tinctorius","volume":"2","author":"Bacchetti","year":"2020","journal-title":"Hydroxy Safflor Yellow A, and Safflor Yellow A. Antioxidants (Basel)."},{"key":"10.1016\/j.phymed.2021.153694_bib0003","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0167-5273(15)31026-3","article-title":"Global burden of CVD: focus on secondary prevention of cardiovascular disease","volume":"1","author":"Bansilal","year":"2015","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"10.1016\/j.phymed.2021.153694_bib0004","doi-asserted-by":"crossref","first-page":"6270","DOI":"10.4238\/2015.June.9.14","article-title":"Hypolipidemic effect of safflower yellow and primary mechanism analysis","volume":"14","author":"Bao","year":"2015","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.phymed.2021.153694_bib0005","first-page":"5386","article-title":"Efficacy of saffower yellow sodium chloride injection combined with trimetazidine in the treatment of unstable angina pectoris and its effect on blood lipids levels and atherosclerotic plaques","volume":"22","author":"Bao","year":"2018","journal-title":"Chin. J. Gerontol."},{"issue":"2","key":"10.1016\/j.phymed.2021.153694_bib0006","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.molmed.2006.12.002","article-title":"Role of the JAK-STAT pathway in myocardial injury","volume":"13","author":"Barry","year":"2007","journal-title":"Trends Mol. Med."},{"issue":"4","key":"10.1016\/j.phymed.2021.153694_bib0007","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/CIRCRESAHA.115.306361","article-title":"Vascular Smooth Muscle Cells in Atherosclerosis","volume":"118","author":"Bennett","year":"2016","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.phymed.2021.153694_bib0008","doi-asserted-by":"crossref","first-page":"C652","DOI":"10.1152\/ajpcell.00022.2011","article-title":"Potential role of insulin signaling on vascular smooth muscle cell migration, proliferation, and inflammation pathways","volume":"302","author":"Cersosimo","year":"2012","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"01","key":"10.1016\/j.phymed.2021.153694_bib0009","first-page":"18","article-title":"The interventional effects of hydroxysafflor yellow A on liver function in hyperlipidemic fatty liver rats","volume":"53","author":"Chai","year":"2018","journal-title":"Jiangxi Med. J."},{"issue":"5","key":"10.1016\/j.phymed.2021.153694_bib0010","doi-asserted-by":"crossref","first-page":"831","DOI":"10.3732\/ajb.0900137","article-title":"Population genetic analysis of safflower (Carthamus tinctorius; Asteraceae) reveals a Near Eastern origin and five centers of diversity","volume":"97","author":"Chapman","year":"2010","journal-title":"Am. J. Bot."},{"key":"10.1016\/j.phymed.2021.153694_bib0011","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.2741\/4443","article-title":"The PI3K\/Akt pathway in the pathogenesis of prostate cancer","volume":"21","author":"Chen","year":"2016","journal-title":"Front. Biosci."},{"issue":"1","key":"10.1016\/j.phymed.2021.153694_bib0012","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/s12870-020-02554-6","article-title":"Integrated metabolomics and transcriptome analysis on flavonoid biosynthesis in safflower (Carthamus tinctorius L.) under MeJA treatment","volume":"20","author":"Chen","year":"2020","journal-title":"BMC Plant Biol."},{"issue":"6","key":"10.1016\/j.phymed.2021.153694_bib0013","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1177\/0960327119831065","article-title":"Hydroxysafflor yellow A attenuates high glucose-induced human umbilical vein endothelial cell dysfunction","volume":"38","author":"Chen","year":"2019","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.phymed.2021.153694_bib0014","first-page":"484","article-title":"Study on Effects of Safflower Yellow Injection on Hemorheology and Neurological function in Patients with Acute Cerebral lnfarction","volume":"37","author":"Cheng","year":"2019","journal-title":"Chin. Arch. Tradit. Chin. Med."},{"key":"10.1016\/j.phymed.2021.153694_bib0015","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.yexmp.2018.01.008","article-title":"Potential of anti-inflammatory agents for treatment of atherosclerosis","volume":"104","author":"Chistiakov","year":"2018","journal-title":"Exp. Mol. Pathol."},{"issue":"5","key":"10.1016\/j.phymed.2021.153694_bib0016","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1055\/s-2005-916249","article-title":"Pharmacokinetics and excretion of hydroxysafflor yellow A, a potent neuroprotective agent from safflower, in rats and dogs","volume":"72","author":"Chu","year":"2006","journal-title":"Planta Med."},{"issue":"04","key":"10.1016\/j.phymed.2021.153694_bib0017","first-page":"475","article-title":"Protective Mechanism of Hydroxysafflor Yellow A on Vascular Endothelial Cells Injured by Oxidative Stress","volume":"39","author":"Cui","year":"2019","journal-title":"J. Hunan Unive. Chin. Med."},{"key":"10.1016\/j.phymed.2021.153694_bib0018","first-page":"2287","article-title":"Clinical study on Safflower Yellow Sodium Chloride Injection combined with propranolol in treatment of angina pectoris of coronary heart disease","volume":"34","author":"Cui","year":"2019","journal-title":"Drugs & Clinic"},{"issue":"24","key":"10.1016\/j.phymed.2021.153694_bib0019","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMra071014","article-title":"Platelet activation and atherothrombosis","volume":"357","author":"Dav\u00ec","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.phymed.2021.153694_bib0020","first-page":"6672","article-title":"Medical uses of Carthamus tinctorius L. (Safflower): a comprehensive review from Traditional Medicine to Modern Medicine","volume":"10","author":"Delshad","year":"2018","journal-title":"Electron Phys."},{"issue":"8","key":"10.1016\/j.phymed.2021.153694_bib0021","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1253\/circj.CJ-14-0621","article-title":"Macrophage phenotypes and their modulation in atherosclerosis","volume":"78","author":"De, Paoli","year":"2014","journal-title":"Circ. J."},{"issue":"05","key":"10.1016\/j.phymed.2021.153694_bib0022","first-page":"663","article-title":"Clinical observation of safflower yellow for injection joint amiodarone treatment of elderly patients with coronary heart disease Ventricular premature beat","volume":"27","author":"Du","year":"2015","journal-title":"Clin. J. Tradit. Chin. Med."},{"issue":"4","key":"10.1016\/j.phymed.2021.153694_bib0023","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/cvr\/cvy010","article-title":"Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness","volume":"114","author":"Durham","year":"2018","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.phymed.2021.153694_bib0024","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/jcp.27575","article-title":"Update on pathological platelet activation in coronary thrombosis","volume":"234","author":"Elia","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.phymed.2021.153694_bib0025","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jep.2017.10.017","article-title":"Effects of Danhong Injection on platelet aggregation in hyperlipidemia rats","volume":"212","author":"Fan","year":"2018","journal-title":"J. Ethnopharmacol."},{"issue":"13","key":"10.1016\/j.phymed.2021.153694_bib0026","first-page":"2564","article-title":"Pharmacokinetics -pharmacodynamics correlation of protocatechuic aldehyde and hydroxysafflor yellow A alone or their combination use in rats with hyperlipidemia","volume":"42","author":"Fan","year":"2017","journal-title":"China J. Chin. Mater. Med."},{"issue":"01","key":"10.1016\/j.phymed.2021.153694_bib0027","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5246\/jcps.2011.01.007","article-title":"Stability and degradation of hydroxysafflor yellow A and anhydrosafflor yellow B in the Safflower injection studied by HPLC\u00adDAD\u00adESI\u00adMS","volume":"20","author":"Fan","year":"2011","journal-title":"J. Chin. Pharm. Sci."},{"key":"10.1016\/j.phymed.2021.153694_bib0028","unstructured":"Falk, E., Shah, P.K., Fuster, V., 2004. Atherothrombosis and thrombosis-prone plaques."},{"key":"10.1016\/j.phymed.2021.153694_bib0029","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-3-319-09665-0_4","article-title":"Cholesterol efflux and reverse cholesterol transport","volume":"224","author":"Favari","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"issue":"06","key":"10.1016\/j.phymed.2021.153694_bib0030","first-page":"448","article-title":"Comparison of Excretion of Hydroxysafflor Yellow A after Oral Administration of Monomer, Medicinal Substance Aqueous Extract and Naodesheng Tablets in Rats","volume":"47","author":"Feng","year":"2012","journal-title":"Chin. Pharm. J."},{"issue":"2","key":"10.1016\/j.phymed.2021.153694_bib0031","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1021\/np300814k","article-title":"NMR Solution Structure Study of the Representative Component Hydroxysafflor Yellow A and Other Quinochalcone C-Glycosides from Carthamus tinctorius","volume":"76","author":"Feng","year":"2013","journal-title":"J. Nat. Prod."},{"issue":"32","key":"10.1016\/j.phymed.2021.153694_bib0032","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.phymed.2021.153694_bib0033","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.cmet.2007.10.007","article-title":"Loss of Akt1 leads to severe atherosclerosis and occlusive coronary artery disease","volume":"6","author":"Fern\u00e1ndez-Hernando","year":"2007","journal-title":"Cell Metab."},{"issue":"9","key":"10.1016\/j.phymed.2021.153694_bib0034","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1007\/s00726-015-1986-1","article-title":"A review and discussion of platelet nitric oxide and nitric oxide synthase: do blood platelets produce nitric oxide from L-arginine or nitrite?","volume":"47","author":"Gambaryan","year":"2015","journal-title":"Amino Acids"},{"issue":"6","key":"10.1016\/j.phymed.2021.153694_bib0035","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1161\/CIRCULATIONAHA.106.621854","article-title":"Advanced glycation end products: sparking the development of diabetic vascular injury","volume":"114","author":"Goldin","year":"2006","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.phymed.2021.153694_bib0036","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00002727-200404000-00003","article-title":"Pathophysiology of diabetes mellitus","volume":"27","author":"Guthrie","year":"2004","journal-title":"Crit. Care Nurs. Q."},{"key":"10.1016\/j.phymed.2021.153694_bib0037","doi-asserted-by":"crossref","first-page":"35319","DOI":"10.1038\/srep35319","article-title":"Hydroxysafflor yellow A alleviates myocardial ischemia\/reperfusion in hyperlipidemic animals through the suppression of TLR4 signaling","volume":"6","author":"Han","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phymed.2021.153694_bib0038","first-page":"848","article-title":"Hydroxysafflor yellow a delays calcification of vascular smooth muscle cells induced by high phosphorus and its mechanism","volume":"11","author":"Han","year":"2019","journal-title":"Chin. J. Nephrol."},{"issue":"1","key":"10.1016\/j.phymed.2021.153694_bib0039","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s13105-015-0382-3","article-title":"Protective effects of hydroxysafflor yellow A (HSYA) on alcohol-induced liver injury in rats","volume":"71","author":"He","year":"2015","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.phymed.2021.153694_bib0040","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s11655-020-3094-7","article-title":"Effect and Safety of Hydroxysafflor Yellow A for Injection in Patients with Acute Ischemic Stroke of Blood Stasis Syndrome: A Phase II, Multicenter, Randomized, Double-Blind, Multiple-Dose, Active-Controlled Clinical Trial","volume":"6","author":"Hu","year":"2020","journal-title":"Chin. J. Integr. Med."},{"issue":"12","key":"10.1016\/j.phymed.2021.153694_bib0041","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1161\/hq1201.100242","article-title":"Sterol efflux mediated by endogenous macrophage ApoE expression is independent of ABCA1","volume":"21","author":"Huang","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"12","key":"10.1016\/j.phymed.2021.153694_bib0042","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s11883-016-0632-z","article-title":"The Different Facets of Dyslipidemia and Hypertension in Atherosclerosis","volume":"18","author":"Hurtubise","year":"2016","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.phymed.2021.153694_bib0043","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2017.05.005","article-title":"Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases","volume":"100","author":"Incalza","year":"2018","journal-title":"Vascul. Pharmacol."},{"issue":"3\u20134","key":"10.1016\/j.phymed.2021.153694_bib0044","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.vph.2008.11.009","article-title":"Effect of Hydroxysafflor yellow A on human umbilical vein endothelial cells under hypoxia","volume":"50","author":"Ji","year":"2009","journal-title":"Vascul. Pharmacol."},{"issue":"3","key":"10.1016\/j.phymed.2021.153694_bib0045","doi-asserted-by":"crossref","first-page":"e92398","DOI":"10.1371\/journal.pone.0092398","article-title":"Positive feedback regulation of proliferation in vascular smooth muscle cells stimulated by lipopolysaccharide is mediated through the TLR4\/Rac1\/Akt pathway","volume":"9","author":"Jiang","year":"2014","journal-title":"PLoS One"},{"issue":"21","key":"10.1016\/j.phymed.2021.153694_bib0046","first-page":"3301","article-title":"Effect of hydroxysafflor yellow A on ABCA1-mediated cholesterol efflux in THP-1 macrophage-derived foam cells","volume":"36","author":"Jiang","year":"2015","journal-title":"Guangdong Med. J."},{"key":"10.1016\/j.phymed.2021.153694_bib0047","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/8519169","article-title":"ROS-Dependent Activation of Autophagy through the PI3K\/Akt\/mTOR Pathway Is Induced by Hydroxysafflor Yellow A-Sonodynamic Therapy in THP-1 Macrophages","author":"Jiang","year":"2017","journal-title":"Oxid. Med. Cell Longev."},{"issue":"04","key":"10.1016\/j.phymed.2021.153694_bib0048","first-page":"67","article-title":"Experimental study on Hydroxy safflower yellow A in fighting atherosis in rabbits","volume":"45","author":"Jin","year":"2011","journal-title":"Shanghai J. Tradit. Chin. Med."},{"issue":"5","key":"10.1016\/j.phymed.2021.153694_bib0049","first-page":"429","article-title":"Inhibitory effect of Hydroxysafflor Yellow A on endothelium inflammatory factors expression elevation induced by platelet activating factor","volume":"30","author":"Jin","year":"2011","journal-title":"J. Cardiovasc. Pulm. Dis."},{"issue":"1","key":"10.1016\/j.phymed.2021.153694_bib0050","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11655-015-1976-x","article-title":"Hydroxysafflor yellow A attenuate lipopolysaccharide-induced endothelium inflammatory injury","volume":"22","author":"Jin","year":"2016","journal-title":"Chin. J. Integr. Med."},{"key":"10.1016\/j.phymed.2021.153694_bib0051","series-title":"Study on Drug Interaction and Bio-active Components of the Herb pair Danggui and Honghua","author":"Jin","year":"2017"},{"key":"10.1016\/j.phymed.2021.153694_bib0052","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jchromb.2016.01.023","article-title":"UFLC-Q-TOF\/MS based screening and identification of the metabolites in plasma, bile, urine and feces of normal and blood stasis rats after oral administration of hydroxysafflor yellow A","author":"Jin","year":"2016","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.phymed.2021.153694_bib0053","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1093\/abbs\/gmr096","article-title":"Changes in cardiac structure and function in rats immunized by angiotensin type 1 receptor peptides","volume":"43","author":"Jin","year":"2011","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"issue":"6","key":"10.1016\/j.phymed.2021.153694_bib0054","doi-asserted-by":"crossref","first-page":"e67020","DOI":"10.1371\/journal.pone.0067020","article-title":"Antibodies against AT1 Receptors Are Associated with Vascular Endothelial and Smooth Muscle Function Impairment: Protective Effects of Hydroxysafflor Yellow A","volume":"8","author":"Jin","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.phymed.2021.153694_bib0055","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.phrs.2013.01.008","article-title":"Ion channel remodeling in vascular smooth muscle during hypertension: Implications for novel therapeutic approaches","volume":"70","author":"Joseph","year":"2013","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phymed.2021.153694_bib0056","series-title":"The Expression of Chalcone Synthase Gene and the Analysis of the A ccumulation of Safflor Yellow in Carthamus tinctorius L","author":"Kang","year":"2014"},{"issue":"5","key":"10.1016\/j.phymed.2021.153694_bib0057","doi-asserted-by":"crossref","first-page":"443","DOI":"10.5551\/jat.RV17001","article-title":"Role of NLRP3 Inflammasomes in Atherosclerosis","volume":"24","author":"Karasawa","year":"2017","journal-title":"J. Atheroscler. Thromb."},{"issue":"9","key":"10.1016\/j.phymed.2021.153694_bib0058","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.2174\/0929867325666180508100950","article-title":"Role of Ox-LDL and LOX-1 in Atherogenesis","volume":"26","author":"Kattoor","year":"2019","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.phymed.2021.153694_bib0059","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12933-018-0763-3","article-title":"Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies","volume":"17","author":"Kaur","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"10.1016\/j.phymed.2021.153694_bib0060","doi-asserted-by":"crossref","first-page":"e8852","DOI":"10.1371\/journal.pone.0008852","article-title":"Macrophage plasticity in experimental atherosclerosis","volume":"5","author":"Khallou-Laschet","year":"2010","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.phymed.2021.153694_bib0061","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1161\/CIRCRESAHA.118.313816","volume":"123","author":"Kobiyama","year":"2018","journal-title":"Atherosclerosis. Circ Res."},{"issue":"1","key":"10.1016\/j.phymed.2021.153694_bib0062","doi-asserted-by":"crossref","first-page":"e2558","DOI":"10.1038\/cddis.2016.354","article-title":"Berberine-sonodynamic therapy induces autophagy and lipid unloading in macrophage","volume":"8","author":"Kou","year":"2017","journal-title":"Cell Death. Dis."},{"issue":"2","key":"10.1016\/j.phymed.2021.153694_bib0063","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0003-2697(83)90700-5","article-title":"The use of amphotericin B to detect inhibitors of cellular cholesterol biosynthesis","volume":"135","author":"Krieger","year":"1983","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.phymed.2021.153694_bib0064","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/S0021-9150(97)00314-6","article-title":"Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance","volume":"137","author":"Laakso","year":"1998","journal-title":"Atherosclerosis"},{"issue":"39","key":"10.1016\/j.phymed.2021.153694_bib0065","doi-asserted-by":"crossref","first-page":"37041","DOI":"10.1074\/jbc.M305213200","article-title":"Reciprocal modulation of Toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase\/Akt by saturated and polyunsaturated fatty acids","volume":"278","author":"Lee","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phymed.2021.153694_bib0066","series-title":"Clinical study on 90 cases of acute cerebral infarction treated with hydroxysafflor yellow A for injection","author":"Li","year":"2008"},{"key":"10.1016\/j.phymed.2021.153694_bib0067","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.2147\/DMSO.S246381","article-title":"Effects of Hydroxysafflor Yellow A on the PI3K\/Akt Pathway and Apoptosis of Pancreatic \u03b2-Cells in Type 2 Diabetes Mellitus Rats","volume":"13","author":"Lee","year":"2020","journal-title":"Diabetes Metab. Syndr. Obes."},{"issue":"2","key":"10.1016\/j.phymed.2021.153694_bib0068","first-page":"20","article-title":"cGMP Signaling and Vascular Smooth Muscle Cell Plasticity","volume":"5","author":"Lehners","year":"2018","journal-title":"J. Cardiovasc. Dev. Dis."},{"key":"10.1016\/j.phymed.2021.153694_bib0069","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jep.2014.12.068","article-title":"Pharmacokinetic profiles of hydroxysafflor yellow A following intravenous administration of its pure preparations in healthy Chinese volunteers","volume":"162","author":"Li","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phymed.2021.153694_bib0070","series-title":"The role of TRPV4 in vascular functional homeostasis","author":"Li","year":"2018"},{"key":"10.1016\/j.phymed.2021.153694_bib0071","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neulet.2012.12.056","article-title":"Hydroxysafflor yellow A suppresses inflammatory responses of BV2 microglia after oxygen-glucose deprivation","volume":"535","author":"Li","year":"2013","journal-title":"Neurosci. Lett."},{"issue":"06","key":"10.1016\/j.phymed.2021.153694_bib0072","first-page":"22","article-title":"Vasodilation and mechanism of action of HSYA on porcine coronary artery","volume":"29","author":"Li","year":"2013","journal-title":"Pharmacol. Clin. Chin. Mater. Med."},{"key":"10.1016\/j.phymed.2021.153694_bib0073","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.neulet.2013.06.007","article-title":"Hydroxysafflor yellow A protects methylglyoxal-induced injury in the cultured human brain microvascular endothelial cells","volume":"549","author":"Li","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.phymed.2021.153694_bib0074","first-page":"821","article-title":"The efficacy and mechanism of apoptosis induction by hypericin-mediated sonodynamic therapy in THP-1 macrophages","volume":"10","author":"Li","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.phymed.2021.153694_bib0075","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1177\/0091270010377633","article-title":"Clinical pharmacokinetics of tonapofylline: evaluation of dose proportionality, oral bioavailability, and gender and food effects in healthy human subjects","volume":"51","author":"Li","year":"2011","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.phymed.2021.153694_bib0076","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.phrs.2018.05.012","article-title":"Oral hydroxysafflor yellow A reduces obesity in mice by modulating the gut microbiota and serum metabolism","volume":"134","author":"Liu","year":"2018","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.phymed.2021.153694_bib0077","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jep.2011.11.016","article-title":"Taoren-Honghua herb pair and its main components promoting blood circulation through influencing on hemorheology, plasma coagulation and platelet aggregation","volume":"139","author":"Liu","year":"2012","journal-title":"J. Ethnopharmacol."},{"issue":"08","key":"10.1016\/j.phymed.2021.153694_bib0078","first-page":"603","article-title":"Effect of safflower yellow on atherosclerosis in rabbits with hyperlipidemia","volume":"45","author":"Liu","year":"2018","journal-title":"J. Int. Pharm. Res."},{"key":"10.1016\/j.phymed.2021.153694_bib0079","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.tox.2004.06.007","article-title":"The subchronic toxicity of hydroxysafflor yellow A of 90 days repeatedly intraperitoneal injections in rats","volume":"203","author":"Liu","year":"2004","journal-title":"Toxicol"},{"issue":"05","key":"10.1016\/j.phymed.2021.153694_bib0080","first-page":"704","article-title":"Determination of hydroxysafflor yellow A in safflower yellow for injection by HPLC","author":"Lu","year":"2006","journal-title":"Chin. Tradit. Herb. Drugs"},{"issue":"09","key":"10.1016\/j.phymed.2021.153694_bib0081","first-page":"625","article-title":"Pharmacokinetics of safflower yellow in the diabetes mellitus patients with renal impairment","volume":"39","author":"Lv","year":"2018","journal-title":"World Clin. Drugs"},{"key":"10.1016\/j.phymed.2021.153694_bib0082","first-page":"4099","article-title":"Enhanced absorption of hydroxysafflor yellow A using a self-double-emulsifying drug delivery system: in vitro and in vivo studies","volume":"7","author":"Lv","year":"2012","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.phymed.2021.153694_bib0083","doi-asserted-by":"crossref","first-page":"15427","DOI":"10.1038\/s41598-017-14692-3","article-title":"Network pharmacology exploration reveals endothelial inflammation as a common mechanism for stroke and coronary artery disease treatment of Danhong injection","volume":"7","author":"Lyu","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.phymed.2021.153694_bib0084","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1208\/s12249-014-0255-z","article-title":"A Novel Oral Preparation of Hydroxysafflor Yellow A Base on a Chitosan Complex: A Strategy to Enhance the Oral Bioavailability","volume":"16","author":"Ma","year":"2015","journal-title":"AAPS Pharm. Sci. Tech."},{"issue":"11","key":"10.1016\/j.phymed.2021.153694_bib0085","first-page":"2694","article-title":"Simultaneous determination of four flavonoids in Carthamus tinotorius of different varieties by HPLC","volume":"41","author":"Ma","year":"2019","journal-title":"Chin. Tradit. Pat. Med."},{"key":"10.1016\/j.phymed.2021.153694_bib0086","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8563845","article-title":"Targeting Early Atherosclerosis: A Focus on Oxidative Stress and Inflammation","author":"Marchio","year":"2019","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.phymed.2021.153694_bib0087","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2147\/VHRM.S20737","article-title":"Optimal therapeutic strategy for treating patients with hypertension and atherosclerosis: focus on olmesartan medoxomil","volume":"7","author":"Mason","year":"2011","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.phymed.2021.153694_bib0088","series-title":"Protective effect and mechanism of HSYA on coronary artery endothelial cell injury","author":"Miao","year":"2019"},{"issue":"6","key":"10.1016\/j.phymed.2021.153694_bib0089","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.018912","article-title":"Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries","volume":"134","author":"Mills","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.phymed.2021.153694_bib0090","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/bs.ircmb.2017.07.007","article-title":"NF-\u03baB and the Transcriptional Control of Inflammation","volume":"335","author":"Mitchell","year":"2018","journal-title":"Int. Rev. Cell Mol. Biol."},{"issue":"2","key":"10.1016\/j.phymed.2021.153694_bib0091","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0165-5728(96)00180-4","article-title":"Structural features and biochemical properties of TNF-\u03b1 converting enzyme (TACE)","volume":"72","author":"Moss","year":"1997","journal-title":"J. Neuroimmunol."},{"issue":"41","key":"10.1016\/j.phymed.2021.153694_bib0092","doi-asserted-by":"crossref","first-page":"E5590","DOI":"10.1073\/pnas.1510574112","article-title":"Motifs of VDAC2 required for mitochondrial Bak import and tBid-induced apoptosis","volume":"112","author":"Naghdi","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.phymed.2021.153694_bib0093","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1248\/bpb.b12-00249","article-title":"Inhibitory effects of hydroxysafflor yellow A on the formation of advanced glycation end products in vitro","volume":"35","author":"Ni","year":"2012","journal-title":"Biol. Pharm. Bull."},{"issue":"3","key":"10.1016\/j.phymed.2021.153694_bib0094","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.jep.2011.11.054","article-title":"The effects of hydroxysafflor yellow A on blood pressure and cardiac function","volume":"139","author":"Nie","year":"2012","journal-title":"J. Ethnopharmacol."},{"issue":"4","key":"10.1016\/j.phymed.2021.153694_bib0095","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1161\/CIRCRESAHA.115.306249","article-title":"Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology","volume":"118","author":"Nordestgaard","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.phymed.2021.153694_bib0096","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2147\/IJN.S18821","article-title":"enhanced effect and mechanism of water-in-oil microemulsion as an oral delivery system of hydroxysafflor yellow A","volume":"6","author":"Qi","year":"2011","journal-title":"Int. J. Nanomed."},{"issue":"21","key":"10.1016\/j.phymed.2021.153694_bib0097","first-page":"157","article-title":"Clinical Efficacy of Hydroxysafflor Yellow A Injection for Acute Ischemic Stroke with Blood Stasis Syndrome Treated","volume":"22","author":"Qin","year":"2016","journal-title":"Chin. J. Exp. Tradit. Med. Formulae."},{"key":"10.1016\/j.phymed.2021.153694_bib0098","series-title":"Effects of safflower yellow on proliferation and Bcl-2\/Bax protein expression of vascular smooth muscle cells","author":"Qin","year":"2009"},{"issue":"11","key":"10.1016\/j.phymed.2021.153694_bib0099","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.3390\/molecules21111480","article-title":"Comparative Analysis of the Effects of Hydroxysafflor Yellow A and Anhydrosafflor Yellow B in Safflower Series of Herb Pairs Using Prep-HPLC and a Selective Knock-Out Approach","volume":"21","author":"Qu","year":"2016","journal-title":"Molecules"},{"issue":"15","key":"10.1016\/j.phymed.2021.153694_bib0100","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1056\/NEJMoa1608664","article-title":"Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes","volume":"376","author":"Rawshani","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.phymed.2021.153694_bib0101","first-page":"2219","article-title":"Safflower's origin and changes of producing areas","volume":"42","author":"Ren","year":"2017","journal-title":"China J. Chin. Mater. Med."},{"issue":"12","key":"10.1016\/j.phymed.2021.153694_bib0102","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.3390\/ijms19123761","article-title":"Role of p38 MAPK in Atherosclerosis and Aortic Valve Sclerosis","volume":"19","author":"Reustle","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.phymed.2021.153694_bib0103","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2165\/00129784-200606040-00003","article-title":"Peroxisome proliferator-activated receptor-gamma agonists for management and prevention of vascular disease in patients with and without diabetes mellitus","volume":"6","author":"R\u00edos-V\u00e1zquez","year":"2006","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"10.1016\/j.phymed.2021.153694_bib0104","first-page":"59","article-title":"Medicinal plants, human health and biodiversity: a broad review","volume":"147","author":"Sen","year":"2015","journal-title":"Adv. Biochem. Eng. Biotechnol."},{"issue":"02","key":"10.1016\/j.phymed.2021.153694_bib0105","first-page":"194","article-title":"Inhibitory effect of hydroxysafflor yellow A on proliferation of vascular smooth muscle cells induced by oxidized low density lipoprotein","volume":"26","author":"Sheng","year":"2012","journal-title":"Chin. J. Pharmacol. Toxicol."},{"issue":"5","key":"10.1016\/j.phymed.2021.153694_bib0106","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.3390\/nu11051155","article-title":"Dietary Fiber, Atherosclerosis, and Cardiovascular Disease","volume":"11","author":"Soliman","year":"2019","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.phymed.2021.153694_bib0107","doi-asserted-by":"crossref","first-page":"e721","DOI":"10.1016\/S2214-109X(20)30117-0","article-title":"Global and regional prevalence, burden, and risk factors for carotid atherosclerosis: a systematic review, meta-analysis, and modelling study","volume":"8","author":"Song","year":"2020","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.phymed.2021.153694_bib0108","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejphar.2016.11.029","article-title":"TLR4\/NF-\u03baB\/Ceramide signaling contributes to Ox-LDL-induced calcification of human vascular smooth muscle cells","volume":"794","author":"Song","year":"2017","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.phymed.2021.153694_bib0109","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3892\/mmr.2014.2336","article-title":"Inhibitory effects of hydroxysafflor yellow A on PDGF\u2011BB\u2011induced proliferation and migration of vascular smooth muscle cells via mediating Akt signaling","volume":"10","author":"Song","year":"2014","journal-title":"Mol. Med. Rep."},{"issue":"05","key":"10.1016\/j.phymed.2021.153694_bib0110","first-page":"95","article-title":"A Study on the Separation of Hydroxysafflor Y ellow A from Safflower Y ellow Pigment","volume":"43","author":"Su","year":"2018","journal-title":"J. Kunming Univ. Sci. Technol. Nat. Sci. Ed."},{"key":"10.1016\/j.phymed.2021.153694_bib0111","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9101740","article-title":"Hydroxysafflor Yellow A Shows Protection against PPAR\u03b3 Inactivation in Nitrosative Neurons","author":"Sun","year":"2018","journal-title":"Oxid. Med. Cell Longev."},{"issue":"5","key":"10.1016\/j.phymed.2021.153694_bib0112","first-page":"2216","article-title":"Effects of MiR-21 on the proliferation and migration of vascular smooth muscle cells in rats with atherosclerosis via the Akt\/ERK signaling pathway","volume":"23","author":"Sun","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.phymed.2021.153694_bib0113","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.ejphar.2017.11.033","article-title":"Protective cerebrovascular effects of hydroxysafflor yellow A (HSYA) on ischemic stroke","volume":"818","author":"Sun","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phymed.2021.153694_bib0114","first-page":"1","article-title":"The mechanism of methyl jasmonate- induced accumulation of Hydroxysafflor yellow A in safflower of different colors","author":"Tan","year":"2020","journal-title":"Acta Pharm. Sin."},{"issue":"7","key":"10.1016\/j.phymed.2021.153694_bib0115","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1161\/CIRCRESAHA.117.309715","article-title":"Gut Microbiota in Cardiovascular Health and Disease","volume":"120","author":"Tang","year":"2017","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.phymed.2021.153694_bib0116","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000007042","article-title":"The impact of risk factors for atherosclerosis on the vasomotor effects of inhibition of nitric oxide synthesis in patients with normal angiograms","volume":"94","author":"Tentolouris","year":"2000","journal-title":"Cardiology"},{"key":"10.1016\/j.phymed.2021.153694_bib0117","article-title":"The sonodynamic effect of curcumin on THP-1 cell-derived macrophages","author":"Wang","year":"2013","journal-title":"Biomed. Res. Int."},{"issue":"05","key":"10.1016\/j.phymed.2021.153694_bib0118","first-page":"353","article-title":"Uptake and Transport of Hydroxysafflor Yellow A in Caco-2 Cells Monolayer","volume":"44","author":"Wang","year":"2009","journal-title":"Chin. Pharm. J."},{"key":"10.1016\/j.phymed.2021.153694_bib0119","series-title":"Study on extraction, purification and stability of hydroxysafflor yellow A","author":"Wang","year":"2007"},{"issue":"5","key":"10.1016\/j.phymed.2021.153694_bib0120","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/ptr.5579","article-title":"Hydroxy-Safflower Yellow A inhibits the TNFR1-Mediated Classical NF-\u03baB Pathway by Inducing Shedding of TNFR1","volume":"30","author":"Wang","year":"2016","journal-title":"Phytother. Res."},{"key":"10.1016\/j.phymed.2021.153694_bib0121","doi-asserted-by":"crossref","first-page":"s27","DOI":"10.5604\/01.3001.0010.5495","article-title":"Cholesterol and Lipoprotein Metabolism and Atherosclerosis: Recent Advances in reverse Cholesterol Transport","volume":"16","author":"Wang","year":"2017","journal-title":"Ann. Hepatol."},{"issue":"01","key":"10.1016\/j.phymed.2021.153694_bib0122","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5428\/pcar20160115","article-title":"Concentration determination of hydroxysafflor yellow A in the plasma of the patients with renal insufficiency by HPLC method","volume":"16","author":"Wang","year":"2016","journal-title":"Pharm. Care Res."},{"issue":"06","key":"10.1016\/j.phymed.2021.153694_bib0123","first-page":"947","article-title":"Study on plasma protein binding rate of hydroxysafflor yellow A in Safflor Yellow Powder Injection","volume":"33","author":"Wang","year":"2011","journal-title":"Chin. Tradit. Pat. Med."},{"key":"10.1016\/j.phymed.2021.153694_bib0124","article-title":"Experimental study on embryo-fetal developmental toxicity of hydroxysafflor yellow A for injection in rats","volume":"1","author":"Wang","year":"2016","journal-title":"Chin. Soc. Toxicol."},{"issue":"47","key":"10.1016\/j.phymed.2021.153694_bib0125","first-page":"4417","article-title":"Effect of the Combination of HSYA and \u03b2-boswellic Acid on Coagulation Function, NO and cGM P in Blood-stasis Model Rats","volume":"25","author":"Wang","year":"2014","journal-title":"China Pharm."},{"key":"10.1016\/j.phymed.2021.153694_bib0126","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172873","article-title":"Hydroxysafflor yellow A actives BK Ca channels and inhibits L-type Ca channels to induce vascular relaxation","volume":"870","author":"Wang","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phymed.2021.153694_bib0127","series-title":"Research on Anti-atherosclerosis Mechanism and Relative Contribution of Hydroxysafflor yellow A in Guanxin \u2161","author":"Wang","year":"2014"},{"key":"10.1016\/j.phymed.2021.153694_bib0128","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.biopha.2017.01.074","article-title":"Hydroxysafflor yellow A promotes neovascularization and cardiac function recovery through HO-1\/VEGF-A\/SDF-1\u03b1 cascade","volume":"88","author":"Wei","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"10","key":"10.1016\/j.phymed.2021.153694_bib0129","first-page":"1680","article-title":"Hydroxysafflor yellow A repairing the metabolic disturbances of early atherosclerosis based on fatty acid profiling","volume":"53","author":"Wei","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"issue":"2","key":"10.1016\/j.phymed.2021.153694_bib0130","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/jms.4041","article-title":"Comprehensive in vitro and in vivo metabolism study of hydroxysafflor yellow A","volume":"53","author":"Wu","year":"2018","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.phymed.2021.153694_bib0131","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8214128","article-title":"Hydroxysafflor Yellow A Attenuates Hydrogen Peroxide-Induced Oxidative Damage on Human Umbilical Vein Endothelial Cells","author":"Xie","year":"2020","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.phymed.2021.153694_bib0132","series-title":"The impact of safflower yellow on oxidative stress and inflammation reactions in type 2 diabetes mellitus patients with atherosclerosis","author":"Xu","year":"2017"},{"issue":"12","key":"10.1016\/j.phymed.2021.153694_bib0133","first-page":"883","article-title":"Improvement of L abrasol on the Oral Absorption of HSYA in Rats","volume":"40","author":"Xu","year":"2016","journal-title":"J. Zhejiang Univ. Tradit. Chin. Med."},{"key":"10.1016\/j.phymed.2021.153694_bib0134","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8172706","article-title":"Hydroxysafflor Yellow A Inhibits LPS-Induced NLRP3 Inflammasome Activation via Binding to Xanthine Oxidase in Mouse RAW264.7 Macrophages","volume":"2016","author":"Xu","year":"2016","journal-title":"Mediators Inflamm."},{"issue":"4","key":"10.1016\/j.phymed.2021.153694_bib0135","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1080\/07391102.2017.1300544","article-title":"Molecular dynamics simulation integrating the inhibition kinetics of hydroxysafflor yellow A on \u03b1-glucosidase","volume":"36","author":"Xu","year":"2017","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.phymed.2021.153694_bib0136","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.brainresbull.2018.05.011","article-title":"Hydroxysafflor yellow a protects brain microvascular endothelial cells against oxygen glucose deprivation\/reoxygenation injury: Involvement of inhibiting autophagy via class I PI3K\/Akt\/mTOR signaling pathway","volume":"140","author":"Yang","year":"2018","journal-title":"Brain Res. Bull."},{"issue":"4","key":"10.1016\/j.phymed.2021.153694_bib0137","first-page":"5295","article-title":"Hydroxysafflor yellow A inhibits lipopolysaccharide-induced proliferation and migration of vascular smooth muscle cells via Toll-like receptor-4 pathway","volume":"8","author":"Yang","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"15","key":"10.1016\/j.phymed.2021.153694_bib0138","doi-asserted-by":"crossref","first-page":"25310","DOI":"10.18632\/oncotarget.15813","article-title":"Oxidative stress-induced apoptosis in granulosa cells involves JNK, p53 and Puma","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.phymed.2021.153694_bib0139","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.112790","article-title":"The vascular dilatation induced by Hydroxysafflor yellow A (HSYA) on rat mesenteric artery through TRPV4-dependent calcium influx in endothelial cells","volume":"256","author":"Yang","year":"2020","journal-title":"J. Ethnopharmacol."},{"issue":"03","key":"10.1016\/j.phymed.2021.153694_bib0140","first-page":"439","article-title":"Activation of myocyte voltage gated K+ channels is involved in HSYA-induced rat coronary arterial relaxation","volume":"36","author":"Yang","year":"2020","journal-title":"Chin. J. Pathophysiol."},{"issue":"5","key":"10.1016\/j.phymed.2021.153694_bib0141","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3390\/molecules21050559","article-title":"The Traditional Medicine and Modern Medicine from Natural Products","volume":"21","author":"Yuan","year":"2016","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.phymed.2021.153694_bib0142","doi-asserted-by":"crossref","first-page":"17981","DOI":"10.1038\/s41598-017-18069-4","article-title":"Proteomic investigation of effects of hydroxysafflor yellow A in oxidized low-density lipoprotein-induced endothelial injury","volume":"7","author":"Ye","year":"2017","journal-title":"Sci. Rep."},{"issue":"01","key":"10.1016\/j.phymed.2021.153694_bib0143","first-page":"30","article-title":"Effect of Hydroxysafflor Yellow A and Panax Notoginseng Saponins on the high-risk factor for Atherosclerosis and Mechanism","volume":"35","author":"Yi","year":"2018","journal-title":"Chin. J. Drug Eval."},{"key":"10.1016\/j.phymed.2021.153694_bib0144","series-title":"E xperimental Study on anti-platelet effect and mechanism of flavonoids in Cartham us tinctorius L","author":"Zang","year":"2006"},{"issue":"11","key":"10.1016\/j.phymed.2021.153694_bib0145","first-page":"2187","article-title":"Endothelium-independent vasodilation effect of hydroxysafflor yellow A in thoracic aorta of Wistar rats","volume":"5","author":"Zhang","year":"2011","journal-title":"J. Med. Plants Res."},{"key":"10.1016\/j.phymed.2021.153694_bib0146","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1142\/S0192415X16500130","article-title":"Phytochemistry and Pharmacology of Carthamus tinctorius L","volume":"44","author":"Zhang","year":"2016","journal-title":"Am. J. Chin. Med."},{"issue":"1-2","key":"10.1016\/j.phymed.2021.153694_bib0147","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijpharm.2017.10.040","article-title":"Solid lipid nanoparticles as carriers for oral delivery of hydroxysafflor yellow A","volume":"535","author":"Zhao","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.phymed.2021.153694_bib0148","first-page":"728","article-title":"Hydroxysafflor yellow A inhibits rat vascular smooth muscle cells proliferation possibly via blocking signal transduction of MEK-ERK1\/2","volume":"43","author":"Zhao","year":"2015","journal-title":"Chin. J. Cardiol."},{"issue":"2","key":"10.1016\/j.phymed.2021.153694_bib0149","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.bbrc.2018.09.036","article-title":"Hydroxysafflor yellow A attenuates high glucose-induced pancreatic \u03b2-cells oxidative damage via inhibiting JNK\/c-jun signaling pathway","volume":"505","author":"Zhao","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phymed.2021.153694_bib0150","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.atherosclerosis.2018.02.015","article-title":"Hyperlipidemia induces typical atherosclerosis development in Ldlr and Apoe deficient rats","volume":"271","author":"Zhao","year":"2018","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.phymed.2021.153694_bib0151","first-page":"520","article-title":"The effect of hydroxy safflower yellow A on coronary heart disease through Bcl-2\/Bax and PPAR-\u03b3","volume":"15","author":"Zhou","year":"2018","journal-title":"Exp. Ther. Med."},{"issue":"4","key":"10.1016\/j.phymed.2021.153694_bib0152","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/10286020310001625120","article-title":"Therapeutic effects of hydroxysafflor yellow A on focal cerebral ischemic injury in rats and its primary mechanisms","volume":"7","author":"Zhu","year":"2005","journal-title":"J. Asian Nat. Prod. Res."},{"issue":"3","key":"10.1016\/j.phymed.2021.153694_bib0153","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3736\/jcim20120311","article-title":"Effects of the Chinese patent medicine, Honghua Injection, on platelet glycoprotein IIb\/III a receptor in patients with acute coronary syndrome: a randomized controlled trial","volume":"10","author":"Zhu","year":"2012","journal-title":"J. Chin. Integr. Med."},{"key":"10.1016\/j.phymed.2021.153694_bib0154","series-title":"Protective effects and mechanism of HSYA and boswellic acids on cerebral ischemia reperfusion and blood stasis syndrome","author":"Zhu","year":"2017"},{"key":"10.1016\/j.phymed.2021.153694_bib0155","series-title":"Studies on the Extraction, Isolation and Antioxidative, Anti-inflammatory Activities of the Flavonoids from Carthamus tinctorius L","author":"Zong","year":"2013"}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711321002373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711321002373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T18:32:54Z","timestamp":1760553174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711321002373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":155,"alternative-id":["S0944711321002373"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2021.153694","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydroxysafflor yellow A, a natural compound from Carthamus tinctorius L with good effect of alleviating atherosclerosis","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2021.153694","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"153694"}}